What is cerebral small vessel disease?

Clinical Neurology

Volumn 51, Issue 6, 2011, Pages 399-405

  Onodera, Osamu ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Capillary; Cerebral small vessel disease; Hereditary cerebral small vessel disease; Pericyte; Perivascular space

Indexed keywords

ANATOMY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN CAPILLARY; CEREBRAL ARTERY DISEASE; CEREBRAL SMALL VESSEL DISEASE; GENE; GLIA; INTERSTITIAL FLUID; MICROANGIOPATHY; PARENCHYMA; PATHOGENESIS; PATHOLOGY; PERICYTE; SMOOTH MUSCLE FIBER; WHITE MATTER;

ARTERIOLES; CAPILLARIES; CEREBROVASCULAR DISORDERS;

EID: 79959984645     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.51.399     Document Type: Article

References (58)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701.
2. Inzitari D, Pracucci G, Poggesi A, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. Bmj 2009;339:b2477-b.
3. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Bmj 2010:341:c3666-c.
4. de Laat KF, Tuladhar AM, van Norden AGW, et al. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain 2010.
5. Weiler RO, Boche D, Nicoll JAR. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathologica 2009;118:87-102.
6. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53. (Pubitemid 41828930)
7. Cleaver O, Melton DA. Endothelial signaling during development Nat Med 2003;9:661-668.
8. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003;3:422-433.
9. Fisher M. Pericyte signaling in the neurovascular unit Stroke 2009;40:S13-15.
10. Gaengel K, Genove G, Armulik A, et al. Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2009;29:630-638.
11. Krueger M, Bechmann I. CNS pericytes: Concepts, misconceptions, and a way out Glia 2010;58:1-10.
12. Ferrer I, Kaste M, Kalimo H. Vasculr disease. In: Louis DN, Ellison DW, Love S, editors. Greenfield's Neuropathology. London: Hodder Headline; 2008. p. 121-151.
13. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nature Reviews Neuroscience 2004;5:347-360. (Pubitemid 38568496)
14. Nonaka H, Akima M, Nagayama T, et al. Microvasculature of the human cerebral meninges. Neuropathology 2003;23:129-135. (Pubitemid 36542416)
15. Akima M. A morphological study on the microcirculation of the central nervous system. Selective vulnerability to hypoxia. Neuropathology 1993;13:99-112.
16. Nonaka H, Akima M, Hatori T, et al. The microvasculature of the cerebral white matter: arteries of the subcortical white matter. J Neuropathol Exp Neurol 2003;62:154-161.
17. Brown WR, Thore CR. Review: Cerebral microvascular pathology in ageing and neurodegeneration. Neuropathology and Applied Neurobiology 2011;37:56-74.
18. Nonaka H, Akima M, Hatori T, et al. Microvasculature of the human cerebral white matter: arteries of the deep white matter. Neuropathology 2003;23:111-118. (Pubitemid 36542414)
19. Nonaka H, Akima M, Nagayama T, et al. The fundamental architecture of the microvasculature of the basal ganglia and changes in senility. Neuropathology 1998;18:47-54.
20. Peters A, Palay SL, Webster H. The Fine Structure of the Nervous System: Neurons and Their Supporting Cells. Third ed. New York: Oxford; 1991.
21. Owens T, Bechmann I, Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol 2008;67:1113-1121.
22. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004;5:347-360.
23. Bechmann I, Galea I, Perry V. What is the blood-brain barrier (not)? Trends in Immunology 2007;28:5-11.
24. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci 2007;10:1369-1376.
25. Armulik A, Genové G, Mäe M, et al: Pericytes regulate the blood-brain barrier. Nature 2010;468:557-561.
26. Attwell D, Buchan AM, Charpak S, et al. Glial and neuronal control of brain blood flow. Nature [Review] 2010;468:232-243.
27. Peppiatt CM, Howarth C, Mobbs P, et al. Bidirectional control of CNS capillary diameter by pericytes. Nature 2006;443:700-704. (Pubitemid 44564713)
28. Yemisci M, Gursoy-Ozdemir Y, Vural A, et al. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nature Medicine 2009;15:1031-1037.
29. Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002;12:358-370. (Pubitemid 34743218)
30. Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathologica 2010;119:277-290.
31. Tanoi Y, Okeda R, Budka H. Binswanger's encephalopathy: serial sections and morphometry of the cerebral arteries. Acta Neuropathologica 2000;100:347-355. (Pubitemid 30497002)
32. Okeda R, Murayama S, Sawabe M, et al. Pathology of the cerebral artery in Binswanger's disease in the aged: observation by serial sections and morphometry of the cerebral arteries. Neuropathology 2004;24:21-29. (Pubitemid 38391491)
33. Akiguchi I, Tomimoto H, Wakita H, et al. Cytopathological alterations and therapeutic approaches in Binswanger's disease. Neuropathology 1999;19:119-128. (Pubitemid 29101445)
34. Lin JX, Tomimoto H, Akiguchi I. et al. Vascular cell components of the medullary arteries in Binswanger's disease brains - A morphometric and immunoelectron microscopic study. Stroke 2000;31:1838-1842. (Pubitemid 30620460)
35. Fisher M, French S, Ji P, et al. Cerebral Microbleeds in the Elderly: A Pathological Analysis. Stroke 2010;41:2782-2785.
36. Lam CK, Yoo T, Hiner B, et al. Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature 2010;465:478-482.
37. Gould DB, Phalan FC, van Mil SE, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006;354:1489-1496.
38. Plaisier E, Gribouval O, Alamowitch S, et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 2007;357:2687-2695.
39. Lanfranconi S, Markus HS. COL4A1 Mutations as a Monogenic Cause of Cerebral Small Vessel Disease: A Systematic Review. Stroke 2010;41:e513-e518.
40. Richards A, van den Maagdenberg AMJM, Jen JC, et al. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nature Genetics 2007;39:1068-1070.
41. Mateen FJ, Krecke K, Younge BR, et al. Evolution of a Tumor-Like Lesion in Cerebroretinal Vasculopathy and Trex1 Mutation. Neurology 2010;75:1211-1213.
42. Kavanagh D, Spitzer D, Kothari PH, et al. New roles for the major human 3′-5′ exonuclease TREX1 in human disease. Cell Cycle 2008;7:1718-1725. (Pubitemid 351988737)
43. Stetson DB, Ko JS, Heidmann T. Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity. Cell 2008;134:587-598.
44. Zarate YA, Hopkin RJ. Fabry's disease. Lancet 2008;372:1427-1435.
45. Fellgiebel A, Müller MJ. Ginsberg L. CNS manifestations of Fabry's disease. The Lancet Neurology 2006;5:791-795.
46. Okeda R, Nisihara M. An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia. Neuropathology 2008;28:532-540.
47. Fukutake T. Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL): From Discovery to Gene Identification. J Stroke Cerebrovasc Dis Epub 2011 Jan 5.
48. Oide T, Nakayama H, Yanagawa S, et al. Extensive loss of arterial medial smooth muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Neuropathology 2008;28:132-142. (Pubitemid 351441697)
49. Hara K, Shiga A, Fukutake T, et al. Association of HTRA 1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med 2009;360:1729-1739.
50. ten Dijke P, Arthur HM. Extracellular control of TGFβ signalling in vascular development and disease. Nature Reviews Molecular Cell Biology 2007;8:857-869.
51. Ishiko A, Shimizu A, Nagata E, et al. Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol 2006;112:333-339. (Pubitemid 44275888)
52. Chabriat H, Joutel A, Dichgans M, et al. Cadasil. Lancet Neurol 2009;8:643-653.
53. Yamamoto Y, Ihara M, Tham C, et al. Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke 2009;40:2004-2011.
54. Joutel A, Monet-Lepretre M, Gosele C, et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. Journal of Clinical Investigation 2010;120:433445.
55. Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, et al. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol 2006;16:30-39.
56. Herzig MC, Van Nostrand WE, Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 2006;16:40-54.
57. Thai DR, Griffin WST, Vos RAI, et al. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathologica 2008;115:599-609.
58. Weiler RO, Subash M, Preston SD, et al. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 2008;18:253-266. (Pubitemid 351430402)